The latest closing stock price for Neurogene as of September 19, 2024 is 41.56.
An investor who bought $1,000 worth of Neurogene stock at the IPO in 2014 would have $-826 today, roughly -1 times their original investment - a -14.70% compound annual growth rate over 11 years.
The all-time high Neurogene stock closing price was 442.60 on August 14, 2015.
The Neurogene 52-week high stock price is 53.00, which is 27.5% above the current share price.
The Neurogene 52-week low stock price is 12.49, which is 69.9% below the current share price.
The average Neurogene stock price for the last 52 weeks is 29.86.
An investor who bought $1,000 worth of Neurogene stock at the IPO in 2014 would have $-826 today, roughly -1 times their original investment - a -14.70% compound annual growth rate over 11 years.
The all-time high Neurogene stock closing price was 442.60 on August 14, 2015.
The Neurogene 52-week high stock price is 53.00, which is 27.5% above the current share price.
The Neurogene 52-week low stock price is 12.49, which is 69.9% below the current share price.
The average Neurogene stock price for the last 52 weeks is 29.86.